Amstelland Hospital in the Netherlands Selects Sectra’s Subscription Model for Enterprise Imaging to Improve Efficiency & Patient Care

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a contract with Amstelland Hospital in the Netherlands. The hospital’s radiology department will be using Sectra’s enterprise imaging solution as a subscription (Sectra One). It will enable future scalability as imaging volumes grow, as well as the possibility of expanding into other specialties.

“It will support us in shaping the digital future of our hospital as it allows us to easily expand to other medical specialties and departments. The solution will also streamline our radiologists’ workflow, provide them with user-friendly tools and enable them to collaborate more effectively to ultimately deliver better patient care. The proven high quality and good service were other important aspects when we chose Sectra,” Dr. Jasper Sluimer, Radiologist and Chief Medical Information Officer at Amstelland Hospital, says and continues: “Our mission is to provide high-quality medical treatments and customer care, provided by motivated staff. The digitalization of healthcare is important for the future; therefore, we are excited about partnering with Sectra and the implementation of their enterprise imaging solution at our hospital.”

Amstelland Hospital is a general hospital located in Amstelveen, the Netherlands. It offers a wide range of medical services, including emergency care, surgery, radiology, cardiology, and rehabilitation. The hospital has over 200 beds and employs around 1,100 healthcare professionals.

The contract, signed in June 2023, provides Sectra’s enterprise imaging solution as a subscription (Sectra One) and Amstelland Hospital will initially implement the radiology and breast imaging software modules.

Sectra’s enterprise imaging solution will provide radiologists with tools that allow them to easily share images and information within their team and between departments. By utilizing a single platform, they will be able to collaborate more easily and work with patients more efficiently.

“Partnering with Amstelland and providing them with Sectra One makes me proud. Our subscription model offers them the flexibility to scale their imaging solution, ensuring that they can continue to provide high-quality care to their patients while adapting to the changing healthcare landscape,” says Peter Osinga, Managing Director, Sectra Benelux and DACH.

Sectra’s enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra’s website to read more about Sectra and why it’s top-ranked in “Best in KLAS“.

SourceSectra

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”